The National Heart, Lung and Blood Institute within the Department of Health and Human Services has issued a pre-solicitation notice for Psomagen Multiplex Olink Proteomics Assays. This procurement falls under the Medical Laboratories NAICS code 621511 and involves quality control, testing, and inspection services classified under PSC code H999. The agency is seeking specialized proteomics assay services that utilize Olink multiplex technology through Psomagen. The notice was posted on June 26, 2025, with the same date listed as the due date, indicating this is likely an initial market survey or sources sought notice rather than a formal solicitation. No specific evaluation criteria have been detailed in this preliminary announcement. The extremely tight timeline suggests interested parties should respond immediately if they wish to participate in the procurement process.

This opportunity does not include any set-aside designations and is open to all qualified contractors. No incumbent contractors or potential award values have been specified in the pre-solicitation documentation. The notice lacks specific quantities of assays to be performed or detailed timelines for service delivery. No budget ranges or contract ceiling amounts have been disclosed at this preliminary stage. The brevity of the notice and absence of detailed specifications suggests this may be an early market research effort to identify capable vendors before issuing a formal request for proposals. Additional information regarding contract scope, performance requirements, and award values will likely be provided in subsequent solicitation documents.

Psomagen Multiplex Olink Proteomics Assays

Opportunity facts

About this opportunity

Notice text

Work this opportunity on GovTribe